A method for detecting hyaluronidase based on surface enhanced Raman technology

By designing the nanoprobe of the nuclear satellite structure of 'Au@4-MPBA@HA/Fe3O4@DTNB@Au@MEA', the surface enhancement Raman technology was used to detect hyaluronidase activity, and the selectivity and sensitivity of the existing methods were solved. The problem of this problem has achieved high sensitivity, specificity and anti-interference detection effects, and is suitable for bladder cancer diagnosis.

CN115078718BActive Publication Date: 2024-11-12FUJIAN NORMAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210870873.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-07-22
Publication Date
2024-11-12
Estimated Expiration
2042-07-22

AI Technical Summary

Technical Problem

The existing hyaluronidase activity detection methods have poor selectivity and sensitivity, and there are problems such as high requirements for the external environment, high cost and high operational difficulty.

Method used

Using a method based on surface enhancement Raman technology, the detection of hyaluronidase activity is improved by designing the nanoprobe of 'Au@4-MPBA@HA/Fe3O4@DTNB@Au@MEA' nuclear satellite structure, and the detection is improved. Sensitivity and specificity.

Benefits of technology

It realizes high sensitivity detection of hyaluronidase activity, reduces detection limit, improves detection accuracy and anti-interference, and is easy to operate and low cost, and is suitable for the detection of complex biological samples.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115078718B_ABST
    Figure CN115078718B_ABST
Patent Text Reader

Abstract

The present invention discloses a method for detecting hyaluronidase based on surface enhanced Raman technology, comprising the following steps: S1: preparation of Au NPs solution; S2: preparation of Au@4-MPBA@HA NPs solution; S3: preparation of Fe3O4@DTNB@Au@MEA substrate; S4: preparation of "Au@4-MPBA@HA / Fe3O4@DTNB@Au@MEA" complex solution; S5: detection of hyaluronidase (HAase). The present invention has high specificity, high sensitivity and high anti-interference, and can quickly and sensitively detect the expression and activity of hyaluronidase (HAase) in the tumor microenvironment.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of enzyme detection, in particular to a method for detecting hyaluronidase based on surface enhanced Raman technology. Background Art

[0002] Hyaluronidase is an endoglycosidase that can specifically degrade hyaluronic acid. Hyaluronidase is a participant in type I allergic reactions. Hyaluronidase is strongly correlated with inflammation and allergies. Studies have reported that various drugs that release histamine from mast cells can regulate hyaluronidase activity. Some anti-allergic drugs have strong inhibitory effects on hyaluronidase activity. Therefore, inhibition of hyaluronidase activity is used as an indicator for studying anti-allergic effects. Hyaluronic acid is widely present in the extracellular matrix and participates in and affects many physiological processes, such as morphological regeneration, wound healing, and tumor invasion. Due to the particularity of hyaluronic acid, hyaluronidase is also related to many physiological and pathological processes. At present, there are many data showing that hyaluronidase is overexpressed in a variety of malignant tumors. Hyaluronidase is inextricably linked to breast cancer, colon cancer, prostate cancer, bladder cancer, etc., among which it is most closely related to bladder cancer and prostate cancer. Studies have shown that the level of hyaluronidase in the urine of patients with bladder cancer is 3-7 times that of normal people. Hyaluronidase can be used as a marker for bladder cancer detection. Therefore, developing a test that can be applied to hyaluronidase in urine is crucial for the diagnosis and treatment of bladder cancer patients.

[0003] Hyaluronidase can specifically decompose hyaluronic acid into small fragments. Hyaluronic acid (HA) is a high molecular weight linear polysaccharide composed of N-acetyl-D-glucosamine and β-glucuronic acid. Many methods for detecting hyaluronidase activity have been developed for this characteristic, such as turbidimetry, viscosity method and zymography. Although these methods are easy to operate, their selectivity and sensitivity are poor. For these shortcomings, fluorescence spectroscopy, colorimetry, immunoassay, etc. have been developed. Although the selectivity and sensitivity are greatly improved compared with traditional methods, there are still many shortcomings. For example, single wavelength emission is usually used when fluorescence spectroscopy is used to detect hyaluronidase activity, which makes the external environment requirements higher, and temperature concentration, etc. will have a greater impact on the experiment, and temperature has a greater impact on enzyme activity, and the experimental results are prone to errors. The cost required for immunoassay is higher, and the operating process and operators are required to be higher. Therefore, it is necessary to develop a hyaluronidase (HAase) detection method that is easy to operate, highly sensitive, and selective. Surface enhanced Raman scattering (SERS) is an ultra-sensitive analytical technique that has been applied in many fields. Compared with fluorescence and colorimetric analysis methods, SERS has the advantages of being resistant to photobleaching and non-invasive, which have great advantages in biomedical detection. Summary of the invention

[0004] The technical problem to be solved by the present invention is that the current detection methods for hyaluronidase activity generally have the disadvantages of poor selectivity and sensitivity. The present invention provides a method for detecting hyaluronidase based on surface enhanced Raman technology. By designing "Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA” “nuclear satellite” structure nanoprobe was used to detect hyaluronidase activity, which improved the detection sensitivity of hyaluronidase activity.

[0005] In order to solve the above technical problems, the technical solution adopted by the present invention is:

[0006] A method for detecting hyaluronidase based on surface enhanced Raman technology comprises the following steps:

[0007] S1: Preparation of Au NPs solution;

[0008] S2: Preparation of Au@4-MPBA@HA NPs solution;

[0009] S3: Preparation of Fe3O4@DTNB@Au@MEA substrate;

[0010] S4: Preparation of Au@4-MPBA@HA / Fe3O4@DTNB@Au@MEA composite solution;

[0011] S5: Detection of HAase.

[0012] Furthermore, the preparation method of the S1 Au NPs solution is as follows: under strong stirring conditions, 1% wt Nact solution and 0.01% wt HAuCl4 solution are mixed in a boiling aqueous solution in a volume ratio of 1:50; when the solution boils again, heating and stirring are continued for 15 minutes to obtain a wine red Au NPs solution.

[0013] Furthermore, the preparation method of the S2 Au@4-MPBA@HA NPs solution is as follows: the purified Au NPs solution is mixed with 1 mM 4-mercaptophenylboronic acid solution in a volume ratio (200:1-100:1), incubated for 2 hours, centrifuged and resuspended in distilled water; 1 mg / mL HA solution is added to the resuspended solution in a volume ratio (20:1-10:1), stirred for 2 hours, and Au@4-MPBA@HANPs solution is obtained.

[0014] Furthermore, the centrifugal conditions in S2 are a rotation speed of 8500 rpm and a time of 12 min.

[0015] Furthermore, the S3 Fe 3 O 4@DTNB@Au@MEA substrate preparation method: 1g of Fe 3 O 4 After being treated with 1 mg / mL PEI and incubated with gold seed solution for 30 min, the Fe 3 O 4 @Au-seed NPs solution; Fe 3 O 4 The Au-seed NPs solution was separated by a magnet, washed, resuspended, and then mixed with 0.1 mM DTNB at a volume ratio of (80:1-120:1) and incubated for 30 min; after incubation, it was separated and washed again by a magnet, and resuspended in deionized water to obtain Fe 3 O 4 @Au-seed@DTNBNPs solution was placed in a mixed solution of 3 mg / mL PVP and 0.5 mg / mL hydroxylamine hydrochloride, with the volume ratio of the former to the latter being (1:15-1:20), and ultrasonicated for 15 minutes, and then 100-500 μL of 1% wt chloroauric acid solution was added thereto and ultrasonicated for 15 minutes.

[0016] Furthermore, the S4 Au@4-MPBA@HA / Fe 3 O 4 Modification preparation method of @DTNB@Au@MEA complex solution: After activating the carboxyl groups on the surface of hyaluronic acid in the Au@4-MPBA@HA NPs solution prepared by S2, the solution was reacted with the Fe 3 O 4 @DTNB@Au@MEA substrate solution was incubated for 2 h to obtain Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA complex solution A, after separation by magnet and washing and resuspending, was mixed with 5%wt bovine serum albumin at a volume ratio of 10:1 and incubated for 1h to obtain Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA composite solution.

[0017] Furthermore, the method for activating the surface carboxyl groups of hyaluronic acid in the Au@4-MPBA@HA NPs solution in S4 is as follows: 20 mg / ml of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 20 mg / ml of N-hydroxysuccinimide are added to the Au@4-MPBA@HA NPs solution in a volume ratio of 1:4 and stirred for 30 minutes.

[0018] Furthermore, the incubation ratio of the complex solution A in S4 is: Au@4-MPBA@HA NPs and Fe 3O 4 @DTNB@Au@MEA was mixed and incubated in a volume ratio (1:1-6:1).

[0019] Further, the detection method of S5 HAase is shown as follows: hyaluronidase with different activities is added to Au@4-MPBA@HA / Fe prepared by S4 3 O 4 @DTNB@Au@MEA complex solution was incubated for 0-150 min, and Raman spectrometer was used to collect Raman spectral information. The excitation wavelength of the Raman spectrometer was 785 nm, and HAase quantitative analysis was performed by Raman spectroscopy processing data.

[0020] Furthermore, the quantitative analysis in S5 was performed by Raman spectroscopy at 1075 cm -1 With 1324cm -1 The intensity ratio was used to quantitatively analyze the HAase activity in the range of 0-25 U·mL -1 Active range, 1075cm -1 With 1324cm -1 There is a linear relationship between the intensity ratio and the hyaluronidase activity, and the working curve is y=0.248x+4.42, R 2 =0.99248.

[0021] The beneficial effects of the present invention are:

[0022] The present invention uses activated Au@4-MPBA@HA NPs and Fe 3 O 4 @DTNB@Au@MEA constructs a sandwich model SERS sensor for detecting HAase (i.e., Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA composite solution), in which HA is used to act as a linker for Fe 3 O 4 @DTNB@Au@MEA and Au@4-MPBA@HA make the detection method of the present invention highly sensitive to HAase, highly anti-interference and highly specific. 3 O 4 The amino capture on @DTNB@Au@MEA constitutes Au@4-MPBA@HA / Fe connected by HA 3 O 4 @DTNB@Au@MEA “sandwich” structure has a good response to the analyte and provides additional amplification of the SERS signal.

[0023] 1. When HAase is added to Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA's "sandwich" model, since HAase cleaves HA, the "sandwich" structure is destroyed, resulting in a weakening of the characteristic peak signal of 4-MPBA. Under the "sandwich" structure, the weakening of the characteristic peak signal is very easy to observe, so the detection method of the present invention has high sensitivity for the detection of HAase.

[0024] 2. The present invention uses activated Au@4-MPBA@HA NPs and Fe 3 O 4 @DTNB@Au@MEA NPs were used to construct a SERS sensor for detecting HAase, which greatly reduced the detection limit of HAase and improved the detection sensitivity of HAase.

[0025] 3. In addition, due to the protection of the gold shell layer, the substrate Fe 3 O 4 The signal of DTNB in ​​@DTNB@Au@MEA hardly changes, so the characteristic peak intensity of DTNB can be used as calibration, so that the obtained data has high precision and accuracy due to calibration. Therefore, it is of great significance to realize the detection of HAase in complex biological samples, that is, using internal standard as reference peak is more suitable for detecting HAase in complex biological samples.

[0026] 4. Experiments have shown that the method for detecting HAase activity provided by the present invention greatly reduces the detection limit of HAase and greatly improves the detection sensitivity in practical applications. Since HAase has specificity in its catalytic effect on HA, the detection method of the present invention has high anti-interference and high specificity. Since L-cysteine, creatinine, glutathione, glucose, urea, amylase, and pepsin cannot break hyaluronic acid, the "sandwich" structure of the present invention will not be destroyed, and the probe molecules will not fall off the magnetic beads, so that the magnetic beads that have completed the reaction are sucked out by a magnet and then the SERS signal is detected. The above interference media are at 1075cm -1 The peak intensity at 1075cm -1 With 1325cm -1 The intensity ratios are higher than those of the experimental group to which HAase was added, so the HAase detection method of the present invention has a high degree of specificity and has no obvious induction to L-cysteine, creatinine, glutathione, glucose, urea, amylase, and pepsin.

[0027] 5. The reagents used in the construction of this scheme are all common and inexpensive chemical reagents, which reduces the detection cost and does not require long-term staining. It can be tested by simply soaking in the test sample for a certain period of time. It is easy to operate and solves the problem that the current methods are either time-consuming or difficult to operate. It is a more economical, faster and more convenient detection method. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] Figure 1 The Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA Flowchart for detecting HAase using the “sandwich” model;

[0029] Figure 2 This is the verification experiment of the present invention. 3 O 4 Sandwich models formed by incubation of @DTNB@Au@MEA substrate with different volume ratios at 1075cm -1 Peak intensity line graph at ;

[0030] Figure 3 To verify the second experiment of the present invention, HAase was added to Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA "sandwich" model at 1075cm after different time -1 A line graph of the peak intensity at ;

[0031] Figure 4 The SERS spectra of HAase with different activities in the third verification experiment of the present invention;

[0032] Figure 5 The concentration of HAase standard and the intensity ratio of characteristic peak (1075 cm -1 / 1323cm -1 ) linear relationship diagram;

[0033] Figure 6 The fourth experiment of the present invention is to verify the presence of different interfering substances at 1075cm -1 With 1323cm -1 Peak intensity ratio histogram at . DETAILED DESCRIPTION

[0034] The technical solutions in the embodiments of the present invention will be described clearly and completely below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0035] In order to better understand the present invention, the present invention is further described below by way of examples. The examples are only used to explain the present invention and do not constitute any limitation to the present invention.

[0036] The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art, and the raw materials used are all commercially available products.

[0037] Embodiment 1

[0038] S1: Preparation of Au NPs solution:

[0039] Under strong stirring, 1.5 ml of 1% wt Nact solution was added to 100 ml of 0.01% wt HAuCl 4 The mixture was mixed in a boiling aqueous solution at a volume ratio of 1:50; when the solution boiled again, heating and stirring were continued for 15 minutes to obtain a wine-red Au NPs solution, which was naturally cooled to room temperature and stored at 4°C for later use.

[0040] S2: Preparation of Au@4-MPBA@HA NPs solution:

[0041] 1) Add 50uL of 1mM 4-mercaptophenylboronic acid solution (4-MPBA) to 10mL of the purified Au NPs solution in S1, incubate for 2h, centrifuge at 8500rpm for 12min, remove excess 4-MPBA, and resuspend in distilled water;

[0042] 2) Add 1 ml of 1 mg / mL HA solution to the solution obtained in S2 1) and stir for 2 h to obtain Au@4-MPBA@HA NPs solution;

[0043] S3:Fe 3 O 4 Preparation of @DTNB@Au@MEA substrate:

[0044] 1) 1g Fe 3 O 4 After being dissolved in PEI (1 mg / mL) alcohol solution and ultrasonicated for 15 min, it was mixed with gold seed solution and incubated for 30 min. The volume ratio of the former to the latter was 1:5.3 O 4 @Au-seed NPs solution;

[0045] 2) Fe obtained from S3 1) 3 O 4 @Au-seed NPs solution was separated by a magnet, washed and resuspended, and then mixed with 0.1mM DTNB and incubated for 30min; the volume ratio of the former to the latter was 100:1.

[0046] 3) Use a magnet to separate and wash to remove excess unreacted DTNB, and resuspend in deionized water to obtain Fe 3 O 4 @Au-seed@DTNB NPs solution; then placed it in a mixed solution of PVP (3 mg / mL) and hydroxylamine hydrochloride (0.5 mg / mL) for 15 minutes, with the volume ratio of the former to the latter being 1:20, and then 300 μL of 1% wt chloroauric acid solution was added thereto and ultrasonicated for 15 minutes.

[0047] S4: Au@4-MPBA@HA / Fe 3 O 4 Preparation of @DTNB@Au@MEA composite solution:

[0048] 1) 20 mg / ml of 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride and 20 mg / ml of N-hydroxysuccinimide were added to the Au@4-MPBA@HA NPs solution at a volume ratio of 1:4 and stirred for 30 min to obtain an activated Au@4-MPBA@HA NPs solution.

[0049] 2) The activated Au@4-MPBA@HA NPs solution was mixed with Fe 3 O 4 The @DTNB@Au@MEA substrate solution was mixed at a volume ratio of 5:1 and incubated for 2 h to obtain Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA complex solution A was separated and washed by magnet, and the resuspended complex solution was mixed with 5%wt bovine serum albumin at a volume ratio of 10:1 and incubated for 1h to obtain Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA composite solution.

[0050] S5: Detection of HAase:

[0051] Au@4-MPBA@HA / Fe was prepared by adding 30U / mL HAase to 200uL S4.3 O 4 @DTNB@Au@MEA complex solution, incubated for 90 min, and the HAase and Au@4-MPBA@HA / Fe 3 O 4 The mixed solution of @DTNB@Au@MEA complex solution was separated and washed, and then dropped onto a clean aluminum plate. The separated product was mainly Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA, Au@4-MPBA@HA / Fe partially acted upon by HAase 3 O 4 @DTNB@Au@MEA and Au@4-MPBA@HA / Fe obtained after being completely acted upon by HAase 3 O 4 @DTNB@Au@MEA. Raman spectrometer was used to collect Raman spectral information. The excitation wavelength of the Raman spectrometer was 785nm. The data was processed by Raman spectroscopy and HAase was quantitatively analyzed.

[0052] Embodiment 2

[0053] S1: Preparation of Au NPs solution:

[0054] Under strong stirring, 1.5 ml of 1% wt Nact solution was added to 100 ml of 0.01% wt HAuCl 4 The mixture was mixed in a boiling aqueous solution at a volume ratio of 1:50; when the solution boiled again, heating and stirring were continued for 15 minutes to obtain a wine-red Au NPs solution, which was naturally cooled to room temperature and stored at 4°C for later use.

[0055] S2: Preparation of Au@4-MPBA@HA NPs solution:

[0056] 1) Add 50uL of 1mM 4-mercaptophenylboronic acid solution (4-MPBA) to the purified Au NPs solution in 5mL S1, incubate for 2h, centrifuge at 8500rpm for 12min, remove excess 4-mercaptophenylboronic acid, and resuspend in distilled water;

[0057] 2) Add 0.25 ml of 1 mg / mL HA solution to the solution obtained in S2 1) and stir for 2 h to obtain Au@4-MPBA@HANPs solution;

[0058] S3:Fe 3 O 4 Preparation of @DTNB@Au@MEA substrate:

[0059] 1) 1g Fe 3 O 4 After being dissolved in PEI (1 mg / mL) alcohol solution and ultrasonicated for 15 min, it was mixed with gold seed solution and incubated for 30 min. The volume ratio of the former to the latter was 1:5. 3 O 4 @Au-seed NPs solution;

[0060] 2) Fe obtained from S3 1) 3 O 4 @Au-seed NPs solution was separated by magnet, washed and resuspended, and then mixed with 0.1 mM DTNB and incubated for 30 min, with the volume ratio of the former to the latter being 120:1;

[0061] 3) Use a magnet to separate and wash to remove excess unreacted DTNB, and resuspend in deionized water to obtain Fe 3 O 4 @Au-seed@DTNB NPs solution; then placed it in a mixed solution of PVP (3 mg / mL) and hydroxylamine hydrochloride (0.5 mg / mL) and ultrasonicated for 15 minutes, the volume ratio of the former to the latter was 1:15, and then 100 μL of 1% wt chloroauric acid solution was added thereto and ultrasonicated for 15 minutes.

[0062] S4: Au@4-MPBA@HA / Fe 3 O 4 Preparation of @DTNB@Au@MEA composite solution:

[0063] 1) 20 mg / ml of 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride and 20 mg / ml of N-hydroxysuccinimide were added to the Au@4-MPBA@HA NPs solution at a volume ratio of 1:4 and stirred for 30 min to obtain an activated Au@4-MPBA@HA NPs solution.

[0064] 2) The activated Au@4-MPBA@HA NPs solution was mixed with 1 mL Fe 3 O 4 The @DTNB@Au@MEA substrate solution was mixed in a volume ratio of 2:1 and incubated for 2 h to obtain Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA complex solution A was separated and washed by magnet, and the resuspended complex solution was mixed with 5%wt bovine serum albumin at a volume ratio of 10:1 and incubated for 1h to obtain Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA composite solution.

[0065] S5: Detection of HAase:

[0066] Au@4-MPBA@HA / Fe was prepared by adding 30U / mL HAase to 200uL S4. 3 O 4 @DTNB@Au@MEA complex solution, incubate for 30 min, and use a magnet to separate the HAase and Au@4-MPBA@HA / Fe 3 O 4 The mixed solution of @DTNB@Au@MEA complex solution was separated and washed, and then dropped onto a clean aluminum plate. The separated product was mainly Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA, Au@4-MPBA@HA / Fe partially acted upon by HAase 3 O 4 @DTNB@Au@MEA and Au@4-MPBA@HA / Fe obtained after being completely acted upon by HAase 3 O 4 @DTNB@Au@MEA. Raman spectrometer was used to collect Raman spectral information. The excitation wavelength of the Raman spectrometer was 785nm. The data was processed by Raman spectroscopy and HAase was quantitatively analyzed.

[0067] Embodiment 3

[0068] S1: Preparation of Au NPs solution:

[0069] Under strong stirring, 1.5 ml of 1% wt Nact solution was added to 100 ml of 0.01% wt HAuCl 4 The boiling aqueous solution was mixed at a volume ratio of 1:50; when the above solution boiled again, it was heated and stirred for 15 minutes to obtain a wine-red Au NPs solution, which was naturally cooled to room temperature and stored at 4°C for later use.

[0070] S2: Preparation of Au@4-MPBA@HA NPs solution:

[0071] 1) Add 50uL of 1mM 4-mercaptophenylboronic acid solution (4-MPBA) to 7.5mL of the purified Au NPs solution in S1, incubate for 2h, centrifuge at 8500rpm for 12min, remove excess 4-MPBA, and resuspend in distilled water;

[0072] 2) Add 0.5 ml of 1 mg / mL HA solution to the solution obtained in S2 1) and stir for 2 h to obtain Au@4-MPBA@HANPs solution;

[0073] S3:Fe 3 O 4 Preparation of @DTNB@Au@MEA substrate:

[0074] 1) 1g Fe 3 O 4 After being dissolved in 5 mL PEI (1 mg / mL) alcohol solution and ultrasonicated for 15 min, it was mixed with the gold seed solution and incubated for 30 min. The volume ratio of the former to the latter was 1:5. The Fe 3 O 4 @Au-seed NPs solution;

[0075] 2) Fe obtained from S3 1) 3 O 4 @Au-seed NPs solution was separated by magnet, washed and resuspended, and then mixed with 0.1 mM DTNB and incubated for 30 min, with the volume ratio of the former to the latter being 80:1;

[0076] 3) Use a magnet to separate and wash to remove excess unreacted DTNB, and resuspend in deionized water to obtain Fe 3 O 4 @Au-seed@DTNB NPs solution; then placed it in a mixed solution of PVP (3 mg / mL) and hydroxylamine hydrochloride (0.5 mg / mL) and ultrasonicated for 15 minutes, the volume ratio of the former to the latter was 1:18, and then 500 μL of 1% wt chloroauric acid solution was added thereto and ultrasonicated for 15 minutes.

[0077] S4: Au@4-MPBA@HA / Fe 3 O 4 Preparation of @DTNB@Au@MEA composite solution:

[0078] 1) 20 mg / ml of 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride and 20 mg / ml of N-hydroxysuccinimide were added to the Au@4-MPBA@HA NPs solution at a volume ratio of 1:4 and stirred for 30 min to obtain an activated Au@4-MPBA@HA NPs solution.

[0079] 2) The activated Au@4-MPBA@HA NPs solution was mixed with 1 mL Fe 3 O 4The @DTNB@Au@MEA substrate solution was mixed in a volume ratio of 3:1 and incubated for 2 h to obtain Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA complex solution A was separated and washed by magnet, and the resuspended complex solution was mixed with 5%wt bovine serum albumin at a volume ratio of 10:1 and incubated for 1h to obtain Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA composite solution.

[0080] S5: Detection of HAase:

[0081] Au@4-MPBA@HA / Fe was prepared by adding 30U / mL HAase to 200uL S4. 3 O 4 @DTNB@Au@MEA complex solution, incubated for 150 min, and the HAase and Au@4-MPBA@HA / Fe 3 O 4 The mixed solution of @DTNB@Au@MEA complex solution was separated and washed, and then dropped onto a clean aluminum plate. The separated product was mainly Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA, Au@4-MPBA@HA / Fe partially acted upon by HAase 3 O 4 @DTNB@Au@MEA and Au@4-MPBA@HA / Fe obtained after being completely acted upon by HAase 3 O 4 @DTNB@Au@MEA. Raman spectrometer was used to collect Raman spectral information. The excitation wavelength of the Raman spectrometer was 785nm. The data was processed by Raman spectroscopy and HAase was quantitatively analyzed.

[0082] Embodiment 4

[0083] S1: Preparation of Au NPs solution:

[0084] Under strong stirring, 1.5 ml of 1% wt Nact solution was added to 100 ml of 0.01% wt HAuCl 4 The boiling aqueous solution was mixed at a volume ratio of 1:50; when the above solution boiled again, it was heated and stirred for 15 minutes to obtain a wine-red Au NPs solution, which was naturally cooled to room temperature and stored at 4°C for later use.

[0085] S2: Preparation of Au@4-MPBA@HA NPs solution:

[0086] 1) Add 50uL of 1mM 4-mercaptophenylboronic acid solution (4-MPBA) to the purified Au NPs solution in S1, incubate for 2h, centrifuge at 8500rpm for 12min, remove excess 4-mercaptophenylboronic acid, and resuspend in distilled water;

[0087] 2) Add 1 ml of 1 mg / mL HA solution to the solution obtained in S2 1) and stir for 2 h to obtain Au@4-MPBA@HA NPs solution;

[0088] S3:Fe 3 O 4 Preparation of @DTNB@Au@MEA substrate:

[0089] 1) 1g Fe 3 O 4 After being dissolved in PEI (1 mg / mL) alcohol solution and ultrasonicated for 15 min, it was mixed with gold seed solution and incubated for 30 min. 3 O 4 @Au-seed NPs solution;

[0090] 2) Fe obtained from S3 1) 3 O 4 @Au-seed NPs solution was separated by magnet, washed and resuspended, and then mixed with 0.1 mM DTNB and incubated for 30 min, with the volume ratio of the former to the latter being 110:1;

[0091] 3) Use a magnet to separate and wash to remove excess unreacted DTNB, and resuspend in deionized water to obtain Fe 3 O 4 @Au-seed@DTNB NPs solution; then placed it in a mixed solution of PVP (3 mg / mL) and hydroxylamine hydrochloride (0.5 mg / mL), with the volume ratio of the former to the latter being 19:20, ultrasonicated for 15 minutes, and then 400 μL of 1% wt chloroauric acid solution was added thereto and ultrasonicated for 15 minutes.

[0092] S4: Au@4-MPBA@HA / Fe 3 O 4 Preparation of @DTNB@Au@MEA composite solution:

[0093] 1) 20 mg / ml of 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride and 20 mg / ml of N-hydroxysuccinimide were added to the Au@4-MPBA@HA NPs solution at a volume ratio of 1:4 and stirred for 30 min to obtain an activated Au@4-MPBA@HA NPs solution.

[0094] 2) The activated Au@4-MPBA@HA NPs solution was mixed with 1 mL Fe 3 O 4 The @DTNB@Au@MEA substrate solution was mixed in a volume ratio of 4:1 and incubated for 2 h to obtain Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA complex solution A was separated and washed by magnet, and the resuspended complex solution was mixed with 5%wt bovine serum albumin at a volume ratio of 10:1 and incubated for 1h to obtain Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA composite solution.

[0095] S5: Detection of HAase:

[0096] Au@4-MPBA@HA / Fe was prepared by adding 30U / mL HAase to 200uL S4. 3 O 4 @DTNB@Au@MEA complex solution, incubated for 60 min, and the HAase and Au@4-MPBA@HA / Fe 3 O 4 The mixed solution of @DTNB@Au@MEA complex solution was separated and washed, and then dropped onto a clean aluminum plate. The separated product was mainly Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA, Au@4-MPBA@HA / Fe partially acted upon by HAase 3 O 4 @DTNB@Au@MEA and Au@4-MPBA@HA / Fe obtained after being completely acted upon by HAase 3 O 4 @DTNB@Au@MEA. Raman spectrometer was used to collect Raman spectral information. The excitation wavelength of the Raman spectrometer was 785nm. The data was processed by Raman spectroscopy and HAase was quantitatively analyzed.

[0097] Embodiment 5-Embodiment 9

[0098] The implementation steps were carried out in accordance with Example 1, except that in step 2) of step S4, the activated Au@4-MPBA@HA NPs solution was mixed with 1 mL Fe 3 O 4The @DTNB@Au@MEA substrate solutions were mixed at volume ratios of 1:1, 2:1, 3:1, 4:1, and 6:1 and incubated for 2 h.

[0099] Embodiment 10 - Embodiment 14

[0100] The implementation steps were carried out in accordance with Example 1, except for the incubation time of HAase in S5. The conditions were as follows: 30 U / mL HAase was added to 200 uL Au@4-MPBA@HA / Fe3O4@DTNB@Au@MEA complex solution and incubated for 0 min, 30 min, 60 min, 120 min, and 150 min, respectively.

[0101] Verification Experiment 1

[0102] The same HA sample was tested by Example 1 and Example 5 to Example 9, and the data obtained are as follows Figure 2 It can be concluded that with the increase of incubation volume ratio, the characteristic peak signal of 4-MPBA gradually increases. When the incubation volume ratio reaches 5:1, the Au@4-MPBA@HA / Fe3O4@DTNB@Au@MEA composite is 1075cm -1 The peak intensity at no longer fluctuates significantly, indicating that the number of probes attached to the substrate has reached saturation.

[0103] Verification Experiment 2

[0104] The same HA sample was tested in Example 1 and Example 10 to Example 14, and the data obtained by using a Raman spectrometer to collect Raman spectrum information are as follows: Figure 3 It can be concluded that as the action time of HAase increases, HAase causes cleavage of HA, the "sandwich" structure is destroyed, and the probe is separated from the magnetic beads, that is, 1075cm -1 The peak intensity at 1324cm -1 There is no significant fluctuation in the peak intensity at 1075 cm -1 With 1325cm -1 The intensity ratio gradually decreased. When the HAase action time reached 90 min, Au@4-MPBA@HA / Fe 3 O 4 @DTNB@Au@MEA composite 1075cm -1 The peak intensity hardly changes any more.

[0105] Verification Experiment 3

[0106] The HAase with different activities (concentrations) was detected using Example 1. HAase with concentrations of 0, 0.001, 0.005, 0.01, 0.05, 0.1, 0.5, 5, 15, 30, and 25 U / ml was detected. The incubation was performed for 90 min. Raman spectrometer was used to collect Raman spectral information. The obtained data is shown in Figure 4 , and sorted the data, selecting the characteristic peak 2226cm in the biological silent zone -1 The working curve was established with HAase activity: y = 0.248x + 4.42, R2 = 0.99248 (e.g. Figure 5 ).

[0107] Verification Experiment 4

[0108] Different samples were tested using Example 1. The HAase in Example 1 was replaced with 100uL 1mM L-cysteine, 1mM creatinine, 1mM glutathione, 1mM glucose, 1mM urea, 30U / mL amylase, 30U / mL pepsin, and deionized water, which were mixed with 200uL Au@4-MPBA@HA / Fe3O4@DTNB@Au@MEA complex and incubated for 90min. The above-mentioned interfering substance complex solutions of different concentrations were separated and washed by a magnet, and then dropped on a clean aluminum plate, and the data spectrum was collected by a laser Raman spectrometer. The data feedback is as follows: Figure 6 (From left to right on the horizontal axis are hyaluronidase, blank control, L-cysteine, amylase, pepsin, creatinine, glutathione, glucose, urea). It can be concluded that the interference media such as L-cysteine, creatinine, glutathione, glucose, urea, amylase, pepsin, etc. are at 1075cm -1 The peak intensity at 1075cm -1 With 1325cm -1 The intensity ratios are all higher than those of the experimental group to which HAase was added, and the HAase detection method of the present invention has a high specificity.

[0109] The above descriptions are merely embodiments of the present invention and are not intended to limit the patent scope of the present invention. Any equivalent structure or equivalent process transformation made using the contents of the present invention specification, or directly or indirectly applied in other related technical fields, are also included in the patent protection scope of the present invention.

[0110] In summary, the present invention provides a method for detecting hyaluronidase based on surface enhanced Raman technology, using activated Au@4-MPBA@HA NPs and Fe 3 O 4@DTNB@Au@MEA constructed a sandwich model SERS sensor for detecting HAase, which has high sensitivity, high specificity and high anti-interference, and can quickly and reliably detect the expression and activity of HAase in the tumor microenvironment.

Claims

1. A method for detecting hyaluronidase based on surface enhanced Raman technology, characterized in that: The following steps are involved: S1: Preparation of Au NPs solution: 1%wt Nact solution and 0.01%wt boiling chloroauric acid aqueous solution were mixed at a volume ratio of 1:50 under strong stirring conditions; when the solution boiled again, heating and stirring were continued for 15 minutes to obtain a wine red Au NPs solution; S2: Preparation of Au@4-MPBA@HA NPs solution: The purified Au NPs solution was mixed with 1 mM 4-mercaptophenylboronic acid solution at a volume ratio of 200:1-100:1, incubated for 2 h, centrifuged at 8500 rpm for 12 min and resuspended in distilled water; 1 mg / mL hyaluronic acid solution was added to the resuspended solution at a volume ratio of 20:1-10:1, stirred for 2 h, and Au@4-MPBA@HANPs solution was obtained; S3: Preparation of Fe3O4@DTNB@Au@MEA substrate: 1g of Fe3O4 was treated with 1mg / mL PEI and then incubated with gold seed solution for 30min to obtain Fe3O4@Au-seed NPs solution; the Fe3O4@Au-seed NPs solution was separated by a magnet, washed and resuspended, and then mixed with 0.1mM DTNB at a volume ratio of 80:1-120:1 and incubated for 30min; after incubation, it was separated and washed again by a magnet, and resuspended in deionized water to obtain Fe3O4@Au-seed@DTNB NPs solution, which was placed in a mixed solution of 3mg / mL PVP and 0.5mg / mL hydroxylamine hydrochloride, with the volume ratio of the former to the latter being 1:15-1:20, and ultrasonicated for 15min, and then 100-500μL of 1%wt chloroauric acid solution was added thereto and ultrasonicated for 15min; S4: Preparation of Au@4-MPBA@HA / Fe3O4@DTNB@Au@MEA complex solution: After activating the surface carboxyl groups of hyaluronic acid in the Au@4-MPBA@HANPs solution prepared in S2, the solution was incubated with the Fe3O4@DTNB@Au@MEA substrate solution prepared in S3 for 2 h to obtain Au@4-MPBA@HA / Fe3O4@DTNB@Au@MEA complex solution A. The complex solution A was separated by a magnet, washed and resuspended, and then mixed with 5% wt bovine serum albumin at a volume ratio of 10:1 and incubated for 1 h to obtain Au@4-MPBA@HA / Fe3O4@DTNB@Au@MEA complex solution; S5: Detection of HAase.

2. The method for detecting hyaluronidase based on surface enhanced Raman technology according to claim 1, characterized in that: The method for activating the surface carboxyl groups of hyaluronic acid in the Au@4-MPBA@HA NPs solution is as follows: 20 mg / ml of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride and 20 mg / ml of N-hydroxysuccinimide are added to the Au@4-MPBA@HA NPs solution in a volume ratio of 1:4 and stirred for 30 minutes.

3. The method for detecting hyaluronidase based on surface enhanced Raman technology according to claim 1, characterized in that: The incubation ratio of the composite solution A is as follows: Au@4-MPBA@HA NPs and Fe3O4@DTNB@Au@MEA are mixed and incubated at a volume ratio of 1:1-6:

1.

4. The method for detecting hyaluronidase based on surface enhanced Raman technology according to claim 1, characterized in that: The HAase detection method is as follows: hyaluronidase HAase with different activities is added to the Au@4-MPBA@HA / Fe3O4@DTNB@Au@MEA complex solution prepared by S4, incubated for 30-150 minutes, and Raman spectrometer is used to collect Raman spectrum information. The excitation wavelength of the Raman spectrometer is 785nm, and HAase quantitative analysis is performed by Raman spectrum processing data.

5. The method for detecting hyaluronidase based on surface enhanced Raman technology according to claim 4, characterized in that: The quantitative analysis is as follows: by Raman spectroscopy at 1075 cm -1 With 1324cm -1 The intensity ratio was used to quantitatively analyze the HAase activity in the range of 0-25 U·mL -1 Active range, 1075cm -1 With 1324cm -1 There is a linear relationship between the intensity ratio and the hyaluronidase activity, and the working curve is y = -0.248x + 4.42, R 2 =0.99248.